跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22 条关于
“Nuvec”
全部
22
临床试验
7
药物
2
机构
2
资讯
11
12个月前
N4 Pharma's Nuvec Delivery System Achieves Targeted RNA Delivery to Lung Cancer Cells
去年
N4 Pharma Assembles Expert Leadership Team to Advance Nuvec® Gene Delivery Platform
去年
N4 Pharma Reports Positive Results from First In Vivo Study of Nuvec® for Inflammatory Bowel Disease
6个月前
N4 Pharma Pivots to RNA Therapeutics with New CEO and Thalia Therapeutics Rebrand
去年
Nuvectis Pharma Reports Financial Results and Highlights Clinical Progress of NXP800 and NXP900
去年
Nuvectis Pharma's NXP800 Shows Promise in ARID1a-Mutated Ovarian Cancer Trial
去年
Nuvectis Pharma to Present Promising NXP900 Data at 2025 AACR Meeting
9个月前
Nuvectis Pharma Initiates Phase 1b Combination Study of NXP900 with Osimertinib for Resistant EGFR-Mutated NSCLC
2个月前
Nuvectis In-Licenses Two Clinical-Stage Assets from Haisco, Transforming into Late-Stage Biopharma with Oral Factor B and Paradox-Breaker BRAF Inhibitors
2年前
NXP800 Receives FDA Orphan Drug Designation for ARID1a-Deficient Ovarian Cancers
第 1 页,共 2 页
上一页
下一页